Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title	Original Publication Date	Journal	Bone Marrow Disease
Clonal dynamics of aplastic anemia/paroxysmal nocturnal hemoglobinuria	Dec 2019	Leukemia & Lymphoma	Aplastic Anemia
Eat and be healthy: nutritional status in myelodysplastic syndromes	Jul 2020	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy	Oct 2020	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions	Jul 2020	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
Raising the bar for lower-risk myelodysplastic syndromes	Apr 2023	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes	May 2019	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes	May 2019	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience	Nov 2020	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis	Jun 2019	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)
Wide Variation in Use and Interpretation of Gene Mutation Profiling Panels Among Health Care Providers of Patients With Myelodysplastic Syndromes: Results of a Large Web-Based Survey	Jun 2020	Leukemia & Lymphoma	Myelodysplastic Syndromes (MDS)